![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GADD45GIP1 |
Gene summary for GADD45GIP1 |
![]() |
Gene information | Species | Human | Gene symbol | GADD45GIP1 | Gene ID | 90480 |
Gene name | GADD45G interacting protein 1 | |
Gene Alias | CKBBP2 | |
Cytomap | 19p13.13 | |
Gene Type | protein-coding | GO ID | GO:0007049 | UniProtAcc | Q8TAE8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
90480 | GADD45GIP1 | SYSMH1 | Human | Oral cavity | OSCC | 6.63e-23 | 9.06e-01 | 0.1127 |
90480 | GADD45GIP1 | SYSMH2 | Human | Oral cavity | OSCC | 6.05e-47 | 2.17e+00 | 0.2326 |
90480 | GADD45GIP1 | SYSMH3 | Human | Oral cavity | OSCC | 3.26e-51 | 2.51e+00 | 0.2442 |
90480 | GADD45GIP1 | SYSMH4 | Human | Oral cavity | OSCC | 1.68e-08 | 4.36e-01 | 0.1226 |
90480 | GADD45GIP1 | SYSMH5 | Human | Oral cavity | OSCC | 9.58e-23 | 1.15e+00 | 0.0647 |
90480 | GADD45GIP1 | SYSMH6 | Human | Oral cavity | OSCC | 1.60e-29 | 1.10e+00 | 0.1275 |
90480 | GADD45GIP1 | GSM5252130_BPH340PrGF_Via | Human | Prostate | BPH | 3.83e-05 | 4.65e-01 | -0.1972 |
90480 | GADD45GIP1 | GSM5252133_BPH389PrSF | Human | Prostate | BPH | 2.64e-02 | 5.87e-01 | -0.2027 |
90480 | GADD45GIP1 | 047563_1562-all-cells | Human | Prostate | BPH | 4.93e-28 | -4.95e-01 | 0.0791 |
90480 | GADD45GIP1 | 048752_1579-all-cells | Human | Prostate | BPH | 1.27e-13 | -4.88e-01 | 0.1008 |
90480 | GADD45GIP1 | 052095_1628-all-cells | Human | Prostate | BPH | 4.68e-12 | -4.68e-01 | 0.1032 |
90480 | GADD45GIP1 | 052097_1595-all-cells | Human | Prostate | BPH | 4.37e-15 | -4.83e-01 | 0.0972 |
90480 | GADD45GIP1 | 052099_1652-all-cells | Human | Prostate | BPH | 5.53e-16 | -5.07e-01 | 0.1038 |
90480 | GADD45GIP1 | Dong_P1 | Human | Prostate | Tumor | 2.01e-29 | 4.19e-02 | 0.035 |
90480 | GADD45GIP1 | Dong_P3 | Human | Prostate | Tumor | 4.95e-15 | 4.82e-03 | 0.0278 |
90480 | GADD45GIP1 | Dong_P4 | Human | Prostate | Tumor | 2.11e-07 | 9.29e-03 | 0.0292 |
90480 | GADD45GIP1 | Dong_P5 | Human | Prostate | Tumor | 5.27e-18 | 3.28e-01 | 0.053 |
90480 | GADD45GIP1 | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 3.73e-02 | -3.60e-01 | 0.1608 |
90480 | GADD45GIP1 | GSM5353227_PA_PR5199-193K_Pool_1_2_3_S55_L002 | Human | Prostate | Tumor | 8.23e-04 | -4.15e-01 | 0.1602 |
90480 | GADD45GIP1 | GSM5353240_PA_PR5254_T1_S15_L001 | Human | Prostate | Tumor | 1.66e-09 | -4.43e-01 | 0.1575 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GADD45GIP1 | SNV | Missense_Mutation | novel | c.47N>T | p.Ala16Val | p.A16V | Q8TAE8 | protein_coding | tolerated(0.58) | benign(0.007) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | deletion | Frame_Shift_Del | rs752340689 | c.585_586delNN | p.Lys196ThrfsTer43 | p.K196Tfs*43 | Q8TAE8 | protein_coding | TCGA-A6-6653-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
GADD45GIP1 | SNV | Missense_Mutation | novel | c.301N>A | p.Glu101Lys | p.E101K | Q8TAE8 | protein_coding | tolerated(0.3) | benign(0.23) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | novel | c.184N>A | p.Ala62Thr | p.A62T | Q8TAE8 | protein_coding | deleterious(0) | benign(0.023) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | rs147251319 | c.566G>A | p.Arg189His | p.R189H | Q8TAE8 | protein_coding | tolerated(0.07) | probably_damaging(0.945) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
GADD45GIP1 | SNV | Missense_Mutation | rs779779033 | c.560G>A | p.Arg187His | p.R187H | Q8TAE8 | protein_coding | deleterious(0) | probably_damaging(0.984) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | rs763367169 | c.521N>A | p.Arg174His | p.R174H | Q8TAE8 | protein_coding | deleterious(0) | probably_damaging(0.96) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | novel | c.585N>T | p.Gln195His | p.Q195H | Q8TAE8 | protein_coding | deleterious(0.01) | possibly_damaging(0.855) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | rs753799047 | c.559C>T | p.Arg187Cys | p.R187C | Q8TAE8 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GADD45GIP1 | SNV | Missense_Mutation | rs755977311 | c.565N>T | p.Arg189Cys | p.R189C | Q8TAE8 | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-EY-A1H0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |